PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns.

Get the weekly brief →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION <1h ago15913 SIGNALS9 FEEDS1262 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
01 Opportunity dossier O-2281 Recurring need documented in 25 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed25 items · 1 source · 8 payment 12-week activity Recency 2026-10-13 02 Opportunity dossier O-1892 Recurring need documented in 7 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed7 items · 2 sources · 7 payment 12-week activity Recency 2026-10-13 03 Opportunity dossier O-1926 Recurring need documented in 5 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed5 items · 2 sources · 4 payment 12-week activity Recency 2026-10-13 04 Cheaper LLM coding alternatives to Claude API Developers spending $1000 on Claude API to code a single app find comparable results on GLM 5.3 for $10, yet lack trusted guidance on cheaper equivalents. Evidence levelPayment-backed10 items · 3 sources · 4 payment 12-week activity Recency 2026-10-13 05 Opportunity dossier O-2418 Recurring need documented in 17 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed17 items · 3 sources · 14 payment 12-week activity Recency 2026-10-13 06 Meta advertising spend and losses reported by beginners Collected sample: 14 independent content items across 2 source families. Known publication dates: 2026-08-08 — 2026-10-12. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed14 items · 2 sources · 11 payment 12-week activity Recency 2026-10-13 07 Opportunity dossier O-6743 Recurring need documented in 12 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed12 items · 2 sources · 8 payment 12-week activity Recency 2026-10-13 08 Opportunity dossier O-2459 Recurring need documented in 15 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed15 items · 2 sources · 10 payment 12-week activity Recency 2026-10-13 09 Claude Max subscriptions and usage limits Collected sample: 25 independent content items across 3 source families. Known publication dates: 2026-07-19 — 2026-09-19. Evidence levelCorroborated25 items · 3 sources · 19 payment 12-week activity Recency Fading · 2026-10-13 10 Opportunity dossier O-3899 Recurring need documented in 13 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed13 items · 1 source · 2 payment 12-week activity Recency 2026-10-13 11 Opportunity dossier O-3184 Recurring need documented in 16 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated16 items · 3 sources · 5 payment 12-week activity Recency Fading · 2026-10-13 12 Opportunity dossier O-2430 Recurring need documented in 22 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed22 items · 1 source · 4 payment 12-week activity Recency 2026-10-13 13 Opportunity dossier O-1368 Recurring need documented in 34 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated34 items · 2 sources · 8 payment 12-week activity Recency Fading · 2026-10-13 14 Opportunity dossier O-3824 Recurring need documented in 7 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed7 items · 1 source · 2 payment 12-week activity Recency 2026-10-13 15 Opportunity dossier O-5510 Recurring need documented in 16 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed16 items · 2 sources · 3 payment 12-week activity Recency 2026-10-13 16 Opportunity dossier O-1431 Recurring need documented in 31 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated31 items · 2 sources · 9 payment 12-week activity Recency Fading · 2026-10-13 17 Opportunity dossier O-4431 Recurring need documented in 18 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed18 items · 2 sources · 6 payment 12-week activity Recency 2026-10-13 18 Opportunity dossier O-1531 Recurring need documented in 27 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated27 items · 2 sources · 3 payment 12-week activity Recency Fading · 2026-10-13 19 Opportunity dossier O-2096 Recurring need documented in 13 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelPayment-backed13 items · 2 sources · 10 payment 12-week activity Recency 2026-10-13 20 Opportunity dossier O-1039 Recurring need documented in 16 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated16 items · 2 sources · 7 payment 12-week activity Recency Fading · 2026-10-13

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.